Tirzepatide and semaglutide have similar list prices, often both over $1,000 per month, with tirzepatide sometimes slightly higher
Brand-name injectable tirzepatide (Mounjaro/Zepbound) costs $1,000 or more per month without insurance but may be covered by some insurance plans
Across the subgroups of patients with different baseline cardiovascular conditions, mean age ranged from approximately 59 to 67 years, baseline BMI from 33.8 to 36.3 kg/m 2 , and baseline type 2 diabetes prevalence from 25.4% in aortic disease to 50.8% in heart failure, with broadly balanced matching across the individual subgroups (Table 2)
Glintborg, D
A lot of these questions will need to be addressed in future studies
Some of the medications listed below are approved by the United States Food and Drug Administration (FDA) for weight loss, while others are prescribed off-label for this purpose